Palatin Technologies Inc (PTN)
0.96
+0.02
(+2.29%)
USD |
NYAM |
Nov 22, 16:00
0.9589
0.00 (0.00%)
Pre-Market: 20:00
Palatin Technologies Free Cash Flow: -32.57M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -32.57M |
| June 30, 2024 | -31.50M |
| March 31, 2024 | -34.68M |
| December 31, 2023 | -27.60M |
| September 30, 2023 | -26.89M |
| June 30, 2023 | -29.71M |
| March 31, 2023 | -27.80M |
| December 31, 2022 | -35.85M |
| September 30, 2022 | -32.43M |
| June 30, 2022 | -30.18M |
| March 31, 2022 | -30.96M |
| December 31, 2021 | -24.91M |
| September 30, 2021 | -32.95M |
| June 30, 2021 | -22.65M |
| March 31, 2021 | -20.19M |
| December 31, 2020 | -19.20M |
| September 30, 2020 | -9.698M |
| June 30, 2020 | 41.26M |
| March 31, 2020 | 40.39M |
| December 31, 2019 | 39.06M |
| September 30, 2019 | 38.49M |
| June 30, 2019 | -21.82M |
| March 31, 2019 | -4.393M |
| December 31, 2018 | -7.780M |
| September 30, 2018 | -5.282M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.681M |
| March 31, 2018 | -21.69M |
| December 31, 2017 | 29.05M |
| September 30, 2017 | 20.91M |
| June 30, 2017 | 12.88M |
| March 31, 2017 | 12.07M |
| December 31, 2016 | -41.65M |
| September 30, 2016 | -44.56M |
| June 30, 2016 | -47.38M |
| March 31, 2016 | -43.15M |
| December 31, 2015 | -38.25M |
| September 30, 2015 | -28.50M |
| June 30, 2015 | -13.36M |
| March 31, 2015 | -8.407M |
| December 31, 2014 | -4.593M |
| September 30, 2014 | -4.437M |
| June 30, 2014 | -12.21M |
| March 31, 2014 | -12.76M |
| December 31, 2013 | -14.57M |
| September 30, 2013 | -11.02M |
| June 30, 2013 | -13.71M |
| March 31, 2013 | -14.08M |
| December 31, 2012 | -13.89M |
| September 30, 2012 | -16.26M |
| June 30, 2012 | -15.50M |
Free Cash Flow Range, Past 5 Years
-35.85M
Minimum
Dec 2022
41.26M
Maximum
Jun 2020
-17.45M
Average
-27.70M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.812M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
| Oragenics Inc | -7.682M |
| Nanoviricides Inc | -7.934M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.016M |
| Cash from Financing (Quarterly) | -0.127M |
| Free Cash Flow Per Share (Quarterly) | -0.3535 |
| Free Cash Flow Yield | -204.1% |